Refine
Year of publication
Document Type
- Article (58)
- Conference Proceeding (5)
- Preprint (1)
- Working Paper (1)
Has Fulltext
- yes (65)
Is part of the Bibliography
- no (65)
Keywords
- HIV (2)
- ACL (1)
- ALK-rearranged NSCLC (1)
- ATM (1)
- Accelerators & Beams (1)
- Accelerators & storage rings (1)
- Antifungal agents (1)
- Antiretroviral therapy (1)
- Aspergillosis (1)
- Atomic & molecular beams (1)
- Atomic, Molecular & Optical (1)
- Autologous stem cell transplantation (1)
- BPDCN (1)
- Beam loss (1)
- CDKN2A (1)
- COVID-19 (1)
- Cancer chemotherapy (1)
- Cancer treatment (1)
- Cell proliferation (1)
- Charge-transfer collisions (1)
- Circular accelerators (1)
- Clinical genetics (1)
- Colorectal cancer (1)
- Culture positive (1)
- DST (1)
- Data sharing (1)
- De-isolation (1)
- Digestive system procedures (1)
- Drug susceptibility testing (1)
- ETP-ALL (1)
- Electronic cigarettes (1)
- Electronic transitions (1)
- Evidence-based guidelines (1)
- Extended donor criteria (1)
- FLT3 (1)
- Fibroblasts (1)
- Fibrotest (1)
- Forschung (1)
- Functional outcome (1)
- Gastric cancer (1)
- HCC (1)
- HCV (1)
- HNO (1)
- Hals-Nasen-Ohren-Heilkunde (1)
- Hematologic malignancies (1)
- Hepatocellular carcinoma (1)
- Hepatotoxicity (1)
- High-dose chemotherapy (1)
- In vitro (1)
- Influenza (1)
- Information Extraction (1)
- Interventional oncological treatment (1)
- Invasive candidiasis (1)
- KRAS (1)
- Laser interstitial thermal therapy (1)
- Lehre (1)
- Lenalidomide (1)
- Liver enzymes (1)
- Low & intermediate-energy accelerators (1)
- M. Intracellulare (1)
- M. avium (1)
- M. avium complex (1)
- M. chimaera (1)
- Marine chemistry (1)
- Menthol (1)
- Microwave ablation (1)
- Motor control (1)
- Multiple myeloma (1)
- Mycobacteria (1)
- Mycobacterium avium complex (1)
- Mycoses (1)
- NOTCH1 (1)
- NRAS (1)
- NTM (1)
- Nicotine (1)
- Non-tuberculous mycobacteria (1)
- Nontuberculous mycobacteria (1)
- Nuclear astrophysics (1)
- Nuclear physics of explosive environments (1)
- Nuclear reactions (1)
- ORL (1)
- Oncogenes (1)
- Open pulmonary tuberculosis (1)
- Opportunistic infections (1)
- Organ allocation (1)
- Otorhinolaryngology (1)
- Palaeoceanography (1)
- Palaeoclimate (1)
- Pancreas transplantation (1)
- Parainfluenza (1)
- Photon counting (1)
- Pneumonia (1)
- Post treatment (1)
- Protease inhibitor therapy (1)
- Psoriasis vulgaris (1)
- Psychiatric disorders (1)
- RTS (1)
- Radiative capture (1)
- Re-injury (1)
- Recurrence (1)
- Regression analysis (1)
- Rehabilitation (1)
- Rejection (1)
- Relapse (1)
- Research (1)
- Residency (1)
- Respiratory infections (1)
- Respiratory syncytial virus (1)
- Return to play (1)
- Return to sports (1)
- SARS-CoV‑2 pandemic (1)
- SARS-CoV‑2-Pandemie (1)
- Sarcopenia (1)
- Second-line treatment (1)
- Secondary prevention (1)
- Semantics (1)
- Specialist training (1)
- Sputum smear-negative (1)
- Superinfection (1)
- Surgical and invasive medical procedures (1)
- Surgical oncology (1)
- T-ALL (1)
- TACE (1)
- TB-therapy (1)
- TP53 mutation status (1)
- Teaching (1)
- Terminology Evolution (1)
- Therapy (1)
- Transarterial chemoembolization (1)
- Transient elastography (1)
- Treatment (1)
- University hospitals (1)
- Universitätskliniken (1)
- Upper respiratory tract infection (1)
- Web Archives (1)
- Weiterbildung (1)
- acute lymphoblastic leukemia (1)
- anti-EGFR therapy (1)
- antimicrobial stewardship (1)
- autoantibodies (1)
- blastic plasmacytoid dendritic cell neoplasm (1)
- cART (1)
- carbapenem resistance (1)
- cardiac magnetic resonance (1)
- chemorefractory metastatic colorectal cancer (1)
- co-infection (1)
- corneas (1)
- deswelling (1)
- global change (1)
- habitat destruction (1)
- infection control (1)
- intraperitoneal therapy (1)
- keratoplasty (1)
- land use (1)
- liver transplantation (1)
- microkeratome (1)
- mitral regurgitation (1)
- mitral valve surgery (1)
- molecular characteristics (1)
- mutually exclusive mutations (1)
- myocardial fibrosis (1)
- next generation sequencing (1)
- peritoneal carcinomatosis (1)
- pressurized intraperitoneal aerosol chemotherapy (PIPAC) (1)
- primary biliary cholangitis (1)
- re-exposure (1)
- rechallenge (1)
- recurrent mutations (1)
- reintroduction (1)
- scar (1)
- second line therapy (1)
- sequential ALK-inhibitor therapy (1)
- sleep disordered breathing (1)
- sorafenib (1)
- transmission (1)
- treatment (1)
- treatment response (1)
- upper gastrointestinal cancer (1)
- ursodeoxycholic acid (1)
- whole-genome sequencing (1)
- x-ray techniques (1)
Institute
Myocardial fibrosis and inflammation by CMR predict cardiovascular outcome in people living with HIV
(2021)
Objectives_: The goal of this study was to examine prognostic relationships between cardiac imaging measures and cardiovascular outcome in people living with human immunodeficiency virus (HIV) (PLWH) on highly active antiretroviral therapy (HAART).
Background: PLWH have a higher prevalence of cardiovascular disease and heart failure (HF) compared with the noninfected population. The pathophysiological drivers of myocardial dysfunction and worse cardiovascular outcome in HIV remain poorly understood.
Methods: This prospective observational longitudinal study included consecutive PLWH on long-term HAART undergoing cardiac magnetic resonance (CMR) examination for assessment of myocardial volumes and function, T1 and T2 mapping, perfusion, and scar. Time-to-event analysis was performed from the index CMR examination to the first single event per patient. The primary endpoint was an adjudicated adverse cardiovascular event (cardiovascular mortality, nonfatal acute coronary syndrome, an appropriate device discharge, or a documented HF hospitalization).
Results: A total of 156 participants (62% male; age [median, interquartile range]: 50 years [42 to 57 years]) were included. During a median follow-up of 13 months (9 to 19 months), 24 events were observed (4 HF deaths, 1 sudden cardiac death, 2 nonfatal acute myocardial infarction, 1 appropriate device discharge, and 16 HF hospitalizations). Patients with events had higher native T1 (median [interquartile range]: 1,149 ms [1,115 to 1,163 ms] vs. 1,110 ms [1,075 to 1,138 ms]); native T2 (40 ms [38 to 41 ms] vs. 37 ms [36 to 39 ms]); left ventricular (LV) mass index (65 g/m2 [49 to 77 g/m2] vs. 57 g/m2 [49 to 64 g/m2]), and N-terminal pro–B-type natriuretic peptide (109 pg/l [25 to 337 pg/l] vs. 48 pg/l [23 to 82 pg/l]) (all p < 0.05). In multivariable analyses, native T1 was independently predictive of adverse events (chi-square test, 15.9; p < 0.001; native T1 [10 ms] hazard ratio [95% confidence interval]: 1.20 [1.08 to 1.33]; p = 0.001), followed by a model that also included LV mass (chi-square test, 17.1; p < 0.001). Traditional cardiovascular risk scores were not predictive of the adverse events.
Conclusions: Our findings reveal important prognostic associations of diffuse myocardial fibrosis and LV remodeling in PLWH. These results may support development of personalized approaches to screening and early intervention to reduce the burden of HF in PLWH (International T1 Multicenter Outcome Study; NCT03749343).
The 33S(n,α)30Si cross section measurement, using 10B(n,α) as reference, at the n_TOF Experimental Area 2 (EAR2) facility at CERN is presented. Data from 0.01 eV to 100 keV are provided and, for the first time, the cross section is measured in the range from 0.01 eV to 10 keV. These data may be used for a future evaluation of the cross section because present evaluations exhibit large discrepancies. The 33S(n,α)30Si reaction is of interest in medical physics because of its possible use as a cooperative target to boron in Neutron Capture Therapy (NCT).
Neutron-induced reaction cross sections are important for a wide variety of research fields ranging from the study of nuclear level densities, nucleosynthesis to applications of nuclear technology like design, and criticality and safety assessment of existing and future nuclear reactors, radiation dosimetry, medical applications, nuclear waste transmutation, accelerator-driven systems and fuel cycle investigations. Simulations and calculations of nuclear technology applications largely rely on evaluated nuclear data libraries. The evaluations in these libraries are based both on experimental data and theoretical models. CERN’s neutron time-of-flight facility n_TOF has produced a considerable amount of experimental data since it has become fully operational with the start of its scientific measurement programme in 2001. While for a long period a single measurement station (EAR1) located at 185 m from the neutron production target was available, the construction of a second beam line at 20 m (EAR2) in 2014 has substantially increased the measurement capabilities of the facility. An outline of the experimental nuclear data activities at n_TOF will be presented.
he study of the resonant structures in neutron-nucleus cross-sections, and therefore of the compound-nucleus reaction mechanism, requires spectroscopic measurements to determine with high accuracy the energy of the neutron interacting with the material under study.
To this purpose, the neutron time-of-flight facility n_TOF has been operating since 2001 at CERN. Its characteristics, such as the high intensity instantaneous neutron flux, the wide energy range from thermal to few GeV, and the very good energy resolution, are perfectly suited to perform high-quality measurements of neutron-induced reaction cross sections. The precise and accurate knowledge of these cross sections plays a fundamental role in nuclear technologies, nuclear astrophysics and nuclear physics.
Two different measuring stations are available at the n_TOF facility, called EAR1 and EAR2, with different characteristics of intensity of the neutron flux and energy resolution. These experimental areas, combined with advanced detection systems lead to a great flexibility in performing challenging measurement of high precision and accuracy, and allow the investigation isotopes with very low cross sections, or available only in small quantities, or with very high specific activity.
The characteristics and performances of the two experimental areas of the n_TOF facility will be presented, together with the most important measurements performed to date and their physics case. In addition, the significant upcoming measurements will be introduced.